CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,597 | -63.7% | 154,291 | -36.4% | 0.00% | – |
| Q2 2023 | $290,942 | +2660.6% | 242,452 | +1717.5% | 0.00% | – |
| Q4 2022 | $10,539 | -94.8% | 13,340 | -94.0% | 0.00% | – |
| Q2 2022 | $203,000 | -24.0% | 221,256 | +48.5% | 0.00% | – |
| Q1 2022 | $267,000 | +196.7% | 149,034 | +155.3% | 0.00% | – |
| Q4 2021 | $90,000 | -77.6% | 58,386 | -70.4% | 0.00% | – |
| Q3 2021 | $401,000 | +1.3% | 197,121 | +73.3% | 0.00% | – |
| Q2 2021 | $396,000 | +1000.0% | 113,764 | +882.9% | 0.00% | – |
| Q3 2017 | $36,000 | – | 11,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |